Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion
Status:
Completed
Trial end date:
2017-08-31
Target enrollment:
Participant gender:
Summary
To evaluate and compare the efficacy and safety of sorafenib versus trans-arterial
chemoembolization plus external beam radiation therapy in patients with hepatocellular
carcinoma invading major intrahepatic vessels